Zusammenfassung
Mit dem sich ändernden Lebensstil hat sich in den letzten Jahren der Sportbegriff wie auch die Einstellung zum Sport vor allem im mittleren und höheren Erwachsenenalter gewandelt; so sind mittlerweile der gesundheitsorientierte Sport und die verschiedenen Formen der Sporttherapie neben dem Breiten-, Wettkampf- und Leistungssport in das Sportverständnis und die Sportmedizin integriert worden. Vermehrte körperliche Aktivität, begleitet von einer gezielten Ernährungsweise gehören zum heute favorisierten, gesunden Lebensstil und stellen erst recht die Grundlage für eine notwendig werdende Therapie von Herz-Kreislauf-Erkrankungen und der mit ihnen verbundenen Stoffwechselstörungen dar. Körperliche Mehraktivität, hier bevorzugt unter Anleitung eines Sportlehrers oder Übungsleiters als Sporttherapie in der Herzgruppe, kann dabei einerseits als unmittelbare Therapieform, andererseits als Motivationhilfe für eine aktive Lebensweise verstanden werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D (1988) Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemost 60: 491–494
Alm’r LO, Janzon L (1975) Low vascular fibrinolytic activity in obesity. Thromb Res 6:171
Alm’r LO, Nilsson IM (1975) On fibrinolysis in diabetes mellitus. Acta Med Scand 198: 101
Americam College of Sports Medicine (1990) The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. Med Sci Sports Exerc 22: 265–274
Andersen P, Arnesen H, Hjermann I (1981) Hyperlipoproteinaemia and reduced fibrinolytic activity in healthy coronary high-risk men. Acta Med Scand 209: 199–202
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC (1992) A comparison of results of meta-analysis of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 268: 240–248
Assmann G, Berg A, Breithard G et al. (1990) Nationale Cholesterin-Initiative: Ein Strategie-Papier zur Erkennung und Behandlung von Hyperlipidämien. Dtsch Ärztebl 87: 1358–1382
Assmann G, Schulte H. PROCAM-Studie (1987) Prospektive Cardiovaskuläre Münster Studie. Panscientia, Hedingen Zürich
Astrand PO (1992) Why exercise. Med Sci Sports Exerc 24: 153–162
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917–1921
Austin MA, King MC, Vranizan K, Krauss RM (1990) Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82: 495–506
Baumstark MW, Berg A, Halle M, Rensing UFE, Roskamm H, Keul J (1992) Low-density lipoprotein subfractions and severity of angiographically assessed coronary artery disease. In: The Second Int. Symposium on Multiple Risk Factors in Cardiovascular Disease. Program & Abstracts. Osaka 83
Baumstark MW, Halle M, Frey I, Berg A, Keul J (1991) Composition and distribution of LDL-subfractions in sedentary and endurance trained men with hypercholesterolemia. In: 9th International Symposium on Atherosclerosis. Abstracts. International Atherosclerosis Society, 193
Berg A (1985) Einfluß der ambulanten Bewegungstherapie (Herzgruppen) auf Herz-Kreislauf- und Stoffwechselgrößen bei Patienten mit Zustand nach Myokardinfarkt. Herz Kreisl 17: 522–528
Berg A, Baumstark MW, Frey I, Halle M, Keul J (1992) Stellenwert des Sports in der Therapie von Dyslipoproteinämien. In: Greten H (Hrsg) Strategien in der Lipidtherapie — heute und morgen. MMV, München, S 79–94
Berg A, Baumstark MW, Frey I, Keul J (1990) Apolipoprotein A-I und B Serumkonzentrationen in einer baden-württembergischen Bevölkerungsstichprobe. GIT Labor Med 5: 255–259
Berg A, Frey I, Baumstark MW, Halle M, Keul J (1993) Sport und Lipide. Lipid Akt 6: 1–9
Berg A, Frey I, Baumstark MW, Halle M, Keul J (1994) Physical activity and lipoprotein lipid disorders. Sports Med 17: 6–21
Berg A, Frey I, Huonker M, Keul J (1994) Lebensstil und Freizeitverhalten von Patienten mit KHK. Der Mediziner 3 (8): 8–14
Berg A, Halle M, Baumstark M, Frey I, Keul J (1991) Einfluß und Wirkweise der körperlichen Aktivität auf den Lipid- und Lipoproteinstoffwechsel. Dtsch Z Sportmed 42: 224–231
Berg A, Halle M, Baumstark M, Frey I, Keul J (1992) Physical activity, lipids and lipoprotein metabolism. The benefit of exercise and training in hyperlipidemia. In: Watson RR, Eisinger M (eds) Exercise and disease. CRC Press, Boca Raton, pp 26–36
Berg A, Halle M, Baumstark MW, Keul J (1994) Bedeutung der Lipoproteine bei der Pathogenese der KHK. Die Rolle der körperlichen Aktivität. Dtsch Ärztebl 91: A822-A830
Berg A, Jakob E, Lehmann M, Dickhuth HH, Huber G, Keul J (1990) Aktuelle Aspekte der modernen Ergometrie. Pneumologie 44: 2–13
Berg A, Johns J, Baumstark M, Kreutz W, Keul J (1983) HDL subfractions after a single, extended episode of physical exercise. Atherosclerosis 47: 231–240
Berg A, Keul J (1984) Validity of predictable effects in metabolic changes. Med Sport Sci 17: 238–249
Berg A, Keul J (1984) (1985) Influence of maximum aerobic capacity and relative body weight on the lipoprotein profile in athletes. Atherosclerosis 55: 225–231
Berg A, Lehmann M, Keul J (1986) Körperliche Aktivität bei Gesunden und Koronarkranken. Thieme, Stuttgart
Berg A, Späth M, Rokitzki L, Staiger J, Keul J (1987) Influence of symptom-limited stress on blood lactate behaviour in coronary heart disease (CHD) patients. Eur Heart J 8:71–75
Blair SN, Kohl III HW, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW (1989) Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262: 2395–2401
Bortz WM (1973) On the control of cholesterol synthesis. Metabolism 22: 1507–1524
Bourey RE, Santoro SA (1988) Interactions of exercise, coagulation, platelets, and fibrinolysis — a brief review. Med Sci Sports Exerc 20: 439–446
Calvalho de Souza J, Soria C, Ayrault-Jarrier M et al. (1988) Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 41: 940–944
Campos H, Bailey SM, Gussak LS, Silex X, Ordovas JM, Schaefer EJ (1991) Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Throm 11: 1077–1088
Campos H, Genest JJ, Blijlevens E et al. (1992) Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12: 187–195
Chance B, Leigh JS, Clark BJ, Maris J, Kent J, Nioka S, Smith D (1985) Control of oxidative metabolism and oxygen delivery in human skeletal muscle: A steady-state analysis of the work/energy cost transfer function. Proc Nat Acad Sci USA 82: 8384–8388
Chandrashekhar Y, Anand IS (1991) Exercise as a coronary protective factor. Am Heart J 122: 1723–1739
Dattilo AM, Krisetherton PM (1992) Effects of weight reduction on blood lipids and lipoproteins — A meta-analysis. Am J Clin Nutr 56: 320–328
Despres JP (1991) Lipoprotein metabolism in visceral obesity. Int J Obesity 15: 45–52
Deutsche Herz-Kreislauf-Präventionsstudie (1988) Nationaler Untersuchungs-Survey und regionale Untersuchungs-Surveys der DHP. DHP Forum, Berichte/Mitteilungen, S 2
DGE Deutsche Gesellschaft für Ernährung eV (1992) Ernährungsbericht 1992. Frankfurt
Dufaux B, Assmann G, Hollmann W (1982) Plasma lipoproteins and physical activity: A review. Int J Sports Med 3: 123–136
Durant RH, Binder CW, Harkess JW, Gray R (1983) The relationship between physical activity and serum lipids and lipoproteins in black children and adolescents. J Adol Health Care 4: 55–60
Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS (1988) Physical fitness as a predictor of cardiovascular mortality in asymptomatic north American men. The Lipid Research Clinic mortality follow-up study. N Engl J Med 319: 1379–1384
Epstein SE, Rosing DR, Brakman P, Redwood DR, Astrup T (1970) Impaired fibrinolytic response to exercise in patients with type IV hyperlipoproteinaemia. Lancet II: 631–634
Estelles A, Tormo G, Aznar J, Espana F, Tormo V (1985) Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exercise. Thromb Res 40: 373–383
Franklin BA, Gordon S, Timmis GC (1992) Amount of exercise necessary for the patient with coronary artery disease. Am J Cardiol 69: 1426–1432
Fraser GE, Phillips RL, Harris RH (1983) Physical fitness and blood pressure in school children. Circulation 67: 405–411
Fripp RR, Hodgson JL, Kwiterovich PO, Werner JC, Schüler HG, Whitman V (1985) Aerobic capacity, obesity, and atherosclerotic risk factors in male adolescents. Pediatry 75: 813–818
Glatz JFC, Vork MM, Cistola DP, Vusse GJ van der (1993) Cytoplasmic fatty acid binding protein: Significance for intracellular transport of fatty acids and putative role on signal transduction pathways. Prostaglandins Leukotrienes Ess Fatty Acids 48: 33–41
Gram J, Jespersen J (1987) A selective depression of tissue plasminogen activator (t-PA) activity in euglobulins characterises a risk group among survivors of acute myocardial infarction. Thromb Haemost 57: 137–139
Griffin BA, Skinner ER, Maughan RJ (1988) The acute effect of prolonged walking and dietary changes on plasma lipoprotein concentrations and high-density lipoprotein subfractions. Metabolism 37: 535–541
Gris JC, Schved JF, Feugeas O, Aquilar-Martinez P, Arnaud A, Sanchez N, Sarlat C (1990) Impact of smoking, physical training and weight reduction on FVII, PAI-1 and hemostatic markers in sedentary men. Thromb Haemost 64: 516–520
Gunnarsson R, Nyman D, Walinder O (1980) Fibrinolytic activity and diabetes control: Evidence for a relationship. Acta Med Scand 639: 23–24
Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK (1988) Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37: 338–345
Halle M, Baumstark MW, Berg A, Frey I, Keul J (1990) Verteilung von LDL-Subfraktionen bei trainierten und untrainierten Hypercholesterinämikern. Z Kardiol 79 (Suppl 2): 53 (Abstr)
Halle M, Baumstark MW, Berg A, Keul J (1991) Verteilung von Low Density Lipoprotein Subfractionen bei männlichen Normalpersonen und Ausdauertrainierten mit und ohne Hypercholesterinämie. In: B ernett P, Jeschke D (Hrsg) Sport und Medizin — pro und contra. Zuckschwerdt, München, S 533–535
Halle M, Berg A, Baumstark MW (1993) Differences in concentration and composition of LDL subfraction particles in hypercholesterolemic men with and without hypertriglyceridemia. Nutr Metab Cardiovasc Dis 3: 179–184
Halle M, Berg A, Baumstark MW, Keul J (1994) Serumtriglyceride als diskriminierender Faktor für die Zahl atherogener Lipoproteinpartikel bei gesunden Männern mit unterschiedlicher Körperkomposition und Fitness. Nieren Hochdruckkrankh (im Druck)
Halle M, Berg A, Frey I, König D, Keul J, Baumstark MW (1994) Relationship of body mass index to LDL subclass phenotype in normoinsulinemic men. Submitted for publication
Hambrecht R, Niebauer J, Marburger C et al. (1993) Various intensities of leisure time physical activity in patients with coronary artery disease: Effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. JACC 22: 468–477
Hamsten A, Walldius G, Szamosi A et al. (1987) Plasminogen activator inhibitor in plasma: Risk for recurrent myocardial infarction. Lancet: 3–8
Hamsten A, Wiman B, DeFaire V, Blombaeck M (1985) Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557–1563
Hansen JB, Olsen JO, Osterud B (1990) Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI). Thromb Haemost 64: 124–126
Haskell WL (1985) Physical activity and health: Need to define the required stimulus. Am J Cardiol 55: 4D–5D
Haskell WL (1985) The influence of exercise training on plasma lipids and lipoproteins in health and disease. Acta Med Scand 711 (Suppl): 25–37
Heimberg MEH, Goh EH, Klusner HJ, Soler-Argilaga C, Weinstein I, Wilcox HG (1978) Regulation of hepatic metabolism of free fatty acids: Interrelationship among secretion of very-low-density lipoproteins, ketogenesis, and cholesterogenesis. In: Dietschy JM, Gotto Jr AM, Ontko JA (eds) Disturbances in lipid and lipoprotein metabolism. Karger, New York, pp 251–267
Heinrich J, Schulte H, Balleisen L, Assmann G, van de Loo J (1991) Predictive value of haemostatic variables in the PROCAM-study. Thromb Haemost 65: 815
Herrick JB (1912) Clinical features of sudden obstruction of the coronary arteries. JAMA 59: 2015–2020
Hurley BF, Nemeth PM, Martin WH, Hagberg JM, Dalsky GP, Holloszy JO (1986) Muscle triglyceride utilisation during exercise: effect of training. J Appl Physiol 60: 562–567
Jansson E, Kaijser L (1987) Substrate utilization and enzymes in skeletal muscle of extremely endurance-trained men. J Appl Physiol 62: 999–1005
Juhan-Vague I, Alessi MC, Joly P et al. (1989) Plasma plasminogen activator inhibitor-1 in angina pectoris: Influence of plasma insulin and acute-phase response. Arteriosclerosis 9: 362–367
Kahn SE, Larson VG, Beard JC et al. (1990) Effect of exercise on insulin action, glucose tolerance and insulin secretion in aging. Am J Physiol 358: E937–E943
Kannel WB, Wolf PA, Castelli WP, D’Agostino RB (1987) Fibrinogen and risk of cardiovascular disease. JAMA 258: 1183–1186
Keil U, Stieber A, Döring A et al. (1988) The cardiovascular risk factor profile in the study aerea Augsburg. Results from the first MONICA survey 1984/1985. Acta Med Scand (Suppl) 728: 119–128
Kern PA, Ong JM, Saffari B, Carty J (1990) The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. N Engl J Med 322: 1053–1059
Keul J (1975) Muscle metabolism during long lasting exercise. In: Howald H, Poortmans JR (eds) Metabolic adaptation to prolonged physical exercise. Birkhäuser, Basel, pp 31–42
Keul J, Doll E, Keppler D (1972) Energy metabolism of human muscle. Karger, Basel
Kiens B, Lithell H (1989) Lipoprotein metabolism influenced by training-induced changes in human skeletal muscle. J Clin Invest 83: 558–564
Klesges RC, Coates TJ, Moldenhauer-Klesges LM, Holzer B, Gustavson J, Barnes J (1984) The FATS: An observational system for assessing physical activity in children and associated parent behavior. Behav Assess 6: 333–345
Klesges RC, Malott JM, Boschee PF, Weber JM (1986) The effects of parental influences on children’s food intake, physical activity and relative body weight. Int J of Eating Disorders 5: 335–346
Koivisto V, Hendler R, Nadel E, Felig P (1982) Influence of physical training on the fuel-hormone response to prolonged low intensity exercise. Metabolism 31: 192–197
König D, Grathwohl D, Baumstark MW, Keul J, Berg A (1993) Eicosanoid-Vorstufen in Plasma und Blutzellen — Bestimmungsmethodik und mögliche Bedeutung für die Regulation der Entzündungslage bei Sportlern. DSÄK, Paderborn
Krauss RM (1987) Relationship of intermediate and lowdensity lipoprotein subspecies to risk of coronary artery disease. Am Heart J 113: 578–582
Krauss RM (1991) The tangled web of coronary risk factors. Am J Med 90 (Suppl 2A): 2A-36S–2A-41S
Krauss RM, Williams PT, Brensike J (1987) Intermediatedensity lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet II: 62–66
Laffel GL, Braumwald E (1984) Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction. N Engl J Med 311: 710–717; 770–776
Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L, Smith U (1990) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39: 1044–1048
Landin K, Tengborn L, Smith U (1990) Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227: 273–278
Leon AS, Connett J, Jacobs DRJ, Rauramaa R (1987) Leisure-time physical activity levels and risk of coronary heart disease and death. JAMA 258: 2388–2395
Levy RI, Brensike JF, Epstein SE et al. (1984) The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention Study. Circulation 69: 325–337
Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP (1988) Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78: 1157–1177
Lowe GDO, Drummond MM, Lorimer AR, Hutton I, Forbes CD, Prentice CRM, Barbenel JC (1980) Relation between extent of coronary artery disease and blood viscosity. Br Heart J 8: 673–674
Lowe GDO, Stromberg P, Forbes CD, McArdle BM, Lorimer AR, Prentice CRM (1982) Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet 27: 472–475
Marti B, Pekkanen (1988) Leben Läufer länger? Schweiz Rundschau Med 41:1097–1100
Marti B, Vartiainen E (1989) Relation between leisure time exercise and cardiovascular risk factors among 15-year-olds in eastern Finnland. J Epid Com Health 43: 228–233
McGinnis JM (1992) The public health burden of a sedentary lifestyle. Med Sci Sports Exerc 24: s196–s200
Meade TW, Brozovic M, Chakrabarti R et al. (1986) Haemostatic function and ischaemic heart disease: principle results of the Northwick Park Heart Study. Lancet 6: 533–537
Meade TW, North WRS, Chakrabarti R (1980) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1:1050–1054
Mehta J, Mehta P, Lawson D, Saldeen T (1987) Plasma tissue plasminogen activator inhibitor levels in coronary artery disease. J Am Coll Cardiol 9: 263–268
Modan M, Or J, Karasik A et al. (1991) Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation 84:1165–1175
Moxley RT, Brakman P, Astrup T (1970) Resting levels of fibrinolysis in blood in inactive and exercising men. J Appl Physiol 28: 549–552
Mussoni L, Mannucci L, Sirtori M, Camera M, Maderna P, Sironi L, Tremoli E (1992) Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscl Thromb 12:19–27
Nordoy A, Illingworth DR, Conner WE, Goodnight S (1990) Increased activity of factor VII and factor VH-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia. Haemostasis 20: 65–72
Nozawa Y, Nakashima S, Nagata K (1991) Phospholipidmediated signaling in receptor activation of human activation of human platelets. Biochim Biophys Acta 1082: 219–238
Nyhan W (1988) Abnormalities in fatty acid oxidation. N Engl J Med 319: 1344–1346
O’Conner GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS, Hennekens CH (1989) An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 80: 234–244
Olofsson BO, Dahlen G, Nilsson TK (1989) Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J 10: 77–82
Ornish D, Brown SE, Scherwitz LW et al. (1990) Can livestyle changes reverse coronary heart disease? Lancet 336: 129–133
Oscai L, Palmer W (1988) Muscle lipolysis during exercise an update. Sports Med 6: 23–28
Paffenbarger RS, Hyde RT, Wing A, Hsieh CC (1986) Physical activity, all-cause mortality and longevity of college alumni. N Engl J Med 314: 605–613
Paffenbarger RS, Hyde RT, Wing AL, Steinmetz CH (1984) A natural history of athleticism and cardiovascular health. JAMA 252: 491–495
Paul P (1975) Effects of long lasting physical exercise and training on lipid metabolism. In: Howald H, Poortmans JR (eds) Metabolic adaptation to prolonged physical exercise. Birkhäuser, Basel, pp 156–193
Pavano JA, Collucci M, van der Wer F (1985) Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J 291: 575–576
Pavlou KN, Krey S, Steffee WP (1989) Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr 49: 1115–1123
Pekkann J, Marti B, Nissinen A, Tuomilehto J, Punsar S, Karvonen MJ (1987) Reduction of premature mortality by high physical activity: 20-year follow-up of middle-aged Finnish men. Lancet 1:1473–1477
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1597–1607
Reichmann H, Rohkamm R, Ricker K, Mertens (1988) Mitochondriale Myopathien. Dtsch Med Wochenschr 113: 106–113
Ren J, Henriksson J, Katz A, Sahlin K (1988) NADH content in type I and type II human muscle fibres after dynamic exercise. Biochem J 251: 183–187
Riddoch C, Savage JM, Murphy N, Cran GW, Boreham C (1991) Long term health implications of fitness and physical activity patterns. Arch Dis Childh 66: 1426–1433
Roskamm H (1993) Langzeittherapie und Sekundärprävention bei Zustand nach Herzinfarkt. RHZ Akt 5/12: 4–12
Sallis JF, Patterson TL, Buono MJ, Nader PR (1988) Relation of cardiovascular fitness and physical activity to cardiovascular disease risk factors in children and adults. Am J Epidemiol 127: 932–941
Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86: 803–811
Sasaki J, Shindo M, Tanaka H, Ando M, Arakawa K (1987) A long-term aerobic exercise program decreases the obesity index and increases the high density lipoprotein cholesterol concentration in obese children. Int J Obesity 11: 339–345
Scherwitz LW, Perkins LL, Chesney MA, Hughes GH, Sidney S, Manolio TA (1992) Hostility and health behaviours in young adults: the Cardia Study. Am J Epidemiol 136:137–145
Schneider SH, Kim HC, Khachadurian AK, Ruderman NB (1988) Impaired fibrinolytic response to exercise in type II diabetes: effects of exercise and physical training. Metabolism 37: 924–929
Schuler G, Hambrecht R, Schlierf G et al. (1992) Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation 86: 1–11
Schwandt P (1990) Cholesterin-Massen-Screening, Ergebnisse einer Pilotstudie mit 127.00 Teilnehmern in Bayern. In: Assmann G, Heinle H, Schulte H (Hrsg) Arteriosklerose, neue Aspekte aus Zellbiologie und Molekulargenetik, Epidemiologie und Klinik. Vieweg, Braunschweig Wiesbaden
Seidel D, Cremer P (1986) Guidelines for the clinical evaluation of risk factors: first report from the Göttinger Risk, Incidence and Prevalence Study. Atheroscl Rev 14: 61–90
Shaw DA, McNaughton D (1963) Relationship between blood fibrinolytic activity and body fatness. Lancet 1:352–354
Siegler IC, Peterson BL, Barefoot JC, Williams RB (1992) Hostility during late adolescence predicts coronary risk factors at mid-life. Am J Epidemiol 136: 146–154
Simpson HCR, Meade TW, Stirling Y, Mann JI, Chakrabartt R, Woolf L (1983) Hypertriglyceridaemia and Hypercoagulability. Lancet 9: 786–790
Slattery ML, Jacobs DR (1988) Physical fitness and cardiovascular disease mortality. Am J Epidemiol 127: 571–580
Speiser W, Langer W, Pschaick A, Selmayr E, Ibe B, Nowacki PE, Muller-Berghaus G (1988) Increased blood fibrinolytic activity after physical exercise: Comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program. Thromb Res 51: 543–555
Stremmel W (1988) Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process. J Clin Invest 81: 844–852
Stremmel W, Diede H (1989) Fatty acid uptake by human hepatoma cell lines represents a carrier-mediated uptake process. Biochim Biophys Acta 1013: 218–222
Tell GS, Vellart OD (1988) Physical fitness, physical activity, and cardiovascular disease risk factors in adolescents: the Oslo youth study. Prev Med 17: 12–24
Thompson PD, Cullinane EM, Sady SP et al. (1988) Modest changes in high density lipoprotein concentration and metabolism with prolonged exercise training. Circulation 78: 25–34
Thompson PD, Cullinane EM, Sady SP, Flynn MM, Chenevert CB, Herbert PN (1991) High density lipoprotein metabolism in endurance athletes and sedentary men. Circulation 84: 140–152
Tornvall P, Karpe F, Carlson LA, Hamsten A (1991) Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 90: 67–80
Vaccaro P, Mahon AD (1989) The effects of exercise on coronary heart disease risk factors in children. Sports Med 8: 139–149
Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35: 250–253
Verheugt FWA, Wouter ten Cate J, Sturk A, Imandt L, Verhorst PMJ, Verwey W, Roos JP (1987) Tissue plasminogen activator (t-PA) activity and inhibition in patients with myocardial infarction and normal coronary arteries. Am J Cardiol 59: 1075–1079
Waxman M, Stunkard AJ (1980) Caloric intake and expenditure of obese boys. J Pediatr 96: 187–193
Weidner G, Hutt J, Connor SL, Mendell NR (1992) Family stress and coronary risk in children. Psychosom Med 54: 471–479
Weiss M, Hupfeld W, Weicker H (1984) Einstellung des optimalen Trainingstempos zur Förderung der lipolytischen Kapazität im Gehen: Übertragbarkeit von Laufbandtests in den Feldversuch. In: Jeschke D (Hrsg) Stellenwert der Sportmedizin in Medizin und Sportwissenschaft. Springer, Berlin Heidelberg New York, S. 207–214
Wilhelmsen L, Ssvärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311: 501–505
Williams PT, Krauss RM, Vranizan KM, Albers JJ, Terry RB, Wood PDS (1989) Effects of exercise-induced weight loss on low density lipoprotein subfractions in healthy men. Arterioscler Thromb 9: 623–632
Williams PT, Krauss RM, Vranizan KM, Albers JJ, Wood PDS (1992) Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and the particle-size distribution of high-density lipoproteins in men. Metabolism 41:441–449
Williams PT, Krauss RM, Vranizan KM, Wood PDS (1990) Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation 81: 1293–1304
Williams PT, Wood PD, Haskell WL, Vranizan K (1982) The effects of running mileage and duration on plasma lipoprotein levels. JAMA 247: 2674–2679
Wirth A, Schlierf G, Schettler G (1979) Körperliche Aktivität und Fettstoffwechsel. Klin Wochenschr 57:1195–1201
Wong ND, Hei TK, Qaqundah PY, Davidson DM, Bassin SL, Gold KV (1992) Television viewing and pediatric hypercholesterolemia. Pediatry 90: 75–79
Wood PD, Stefanick ML, Dreon DM et al. (1988) Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 319: 1173–1179
Wood PD, Stefanick ML, Williams PT, Haskell WL (1991) The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 325: 461–466
Yalow RS, Glick SM, Roth J (1965) Plasma insulin and growth hormone levels in obesity and diabetes. Ann N Y Acad Sci 131: 357–373
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Berg, A., Halle, M., Ahlgrimm, E., Keul, J. (1995). Ambulante Langzeitrehabilitation am Wohnort. In: Unger, F., Mörl, H., Dieterich, H.A. (eds) Interventionen am Herzen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93558-9_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-93558-9_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-93559-6
Online ISBN: 978-3-642-93558-9
eBook Packages: Springer Book Archive